SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-19-000012
Filing Date
2019-02-07
Accepted
2019-02-07 17:28:13
Documents
57
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12311810qaxovant.htm 10-Q 1210637
2 EXHIBIT 10.1 a123118exhibit101.htm EX-10.1 158887
3 EXHIBIT 31.1 a123118exhibit311.htm EX-31.1 10210
4 EXHIBIT 31.2 a123118exhibit312.htm EX-31.2 10134
5 EXHIBIT 32.1 a123118exhibit321.htm EX-32.1 6335
6 EXHIBIT 32.2 a123118exhibit322.htm EX-32.2 6195
  Complete submission text file 0001636050-19-000012.txt   4032405

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT axon-20181231.xml EX-101.INS 453566
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20181231.xsd EX-101.SCH 36152
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20181231_cal.xml EX-101.CAL 49045
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20181231_def.xml EX-101.DEF 157722
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20181231_lab.xml EX-101.LAB 432540
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20181231_pre.xml EX-101.PRE 256399
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 19576171
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1